Invention Grant
- Patent Title: Identification of antitumor compounds using placenta
- Patent Title (中): 使用胎盘鉴定抗肿瘤化合物
-
Application No.: US14380014Application Date: 2013-02-22
-
Publication No.: US09575054B2Publication Date: 2017-02-21
- Inventor: Robert J. Hariri , Mohit B. Bhatia , Qian Ye
- Applicant: Anthrogenesis Corporation
- Applicant Address: US NJ Warren
- Assignee: Anthrogenesis Corporation
- Current Assignee: Anthrogenesis Corporation
- Current Assignee Address: US NJ Warren
- Agent Timothy L. Smith; Colin A. Forestal
- International Application: PCT/US2013/027288 WO 20130222
- International Announcement: WO2013/126674 WO 20130829
- Main IPC: G01N33/574
- IPC: G01N33/574 ; G01N33/50

Abstract:
Provided herein are methods of evaluating potential antitumor compounds, and thereby identifying antitumor compounds, using placenta or a portion thereof and tumor cells, and compositions for accomplishing the same. In one embodiment, provided herein is a method of determining whether a potential antitumor compound is effective against a plurality of tumor cells, comprising introducing a plurality of tumor cells to, e.g., into or onto, a mammalian placenta or portion thereof; contacting said plurality of tumor cells for a period of time with said antitumor compound; and determining whether said antitumor compound is effective against said tumor cells, wherein said antitumor compound is effective against said tumor cells if said antitumor compound over said period of time reduces the number of said tumor cells or reduces the growth rate of said tumor cells.
Public/Granted literature
- US20150017663A1 IDENTIFICATION OF ANTITUMOR COMPOUNDS USING PLACENTA Public/Granted day:2015-01-15
Information query
IPC分类: